Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
Background Data for front-line health-care workers and risk of COVID-19 are limited. We
sought to assess risk of COVID-19 among front-line health-care workers compared with the …
sought to assess risk of COVID-19 among front-line health-care workers compared with the …
[HTML][HTML] Attributes and predictors of long COVID
Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called ‘long
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …
…, S Selvachandran, L Polidori, A May, J Wolf… - The Lancet Infectious …, 2022 - thelancet.com
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta‐analyses to determine first‐line treatments
DJ Lee, CW Schnitzlein, JP Wolf… - Depression and …, 2016 - Wiley Online Library
Background Current clinical practice guidelines (CPGs) for posttraumatic stress disorder (PTSD)
offer contradictory recommendations regarding use of medications or psychotherapy as …
offer contradictory recommendations regarding use of medications or psychotherapy as …
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
[HTML][HTML] Real-time tracking of self-reported symptoms to predict potential COVID-19
A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a
smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion …
smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion …
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a …
Background The SARS-CoV-2 variant of concern, omicron, appears to be less severe than
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4
Metagenomic assembly enables new organism discovery from microbial communities, but it
can only capture few abundant organisms from most metagenomes. Here we present …
can only capture few abundant organisms from most metagenomes. Here we present …
Human postprandial responses to food and potential for precision nutrition
Metabolic responses to food influence risk of cardiometabolic disease, but large-scale high-resolution
studies are lacking. We recruited n = 1,002 twins and unrelated healthy adults in …
studies are lacking. We recruited n = 1,002 twins and unrelated healthy adults in …
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
Background With the surge of new SARS-CoV-2 variants, countries have begun offering
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
